West Pharmaceutical Services, Inc. (West) has recently announced its partnership with Haryana based pharma company Venus Remedies Ltd. whose brand Cloti-Xa™ has made its introduction in the growing low molecular weight heparin market and has adopted the NovaGuard^® SA Pro safety system, a single-use accessory for prefilled ISO standard 1mL long staked-needle syringes.

The NovaGuard^® SA Pro safety system is a product with innovative safety features that help protect healthcare workers and patients from accidental needlestick injuries. Several biopharmaceutical manufacturers have commented that this product delivers a compelling total cost of ownership in that it prevents pre-activation, offers a lower syringe snap-in force and a lower activation force for end-user comfort, and mitigates the practice of recapping which helps to provide tamper evidence to customers.  

Alagu Subramaniam, Managing Director, West India said, “We at West are committed to improving patients’ health and are excited to extend our partnership with Venus Remedies on this new product launch, by delivering unique and innovative packaging products and services. This partnership helps us bring the benefits of our innovative NovaGuard^® SA Pro safety system to the India market, and we will continue to extend the range of our innovative solutions to local customers and patients worldwide.”

The NovaGuard^® SA Pro safety system:

• Has been designed to prevent pre-activation during handling;
• Includes tamper-resistant functionality;
• Provides transparency for drug inspection and labeling;
• Has an ease-of-use assembly